Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.50
-0.10 (-1.32%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Affordable Medicines
1.69B
Log In
Log In
Log In
Log In
Upgrade
Affordable Medicines Growth
14.53%
Log In
Log In
Log In
Log In
Upgrade
AvKARE
662.95M
Log In
Log In
Log In
Log In
Upgrade
AvKARE Growth
24.67%
Log In
Log In
Log In
Log In
Upgrade
Specialty
445.75M
Log In
Log In
Log In
Log In
Upgrade
Specialty Growth
14.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States, India and Ireland
2.79B
Log In
Log In
Log In
Log In
Upgrade
United States, India and Ireland Growth
16.73%
Log In
Log In
Log In
Log In
Upgrade